US Patent 7989585 Chronic treatment regimen using glucagon-like insulinotropic peptides

Patent 7989585 was granted and assigned to Eli Lilly and Company on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7989585

Date of Patent

August 2, 2011

Patent Application Number

11836814

Date Filed

August 10, 2007

Patent Primary Examiner

‌

David Lukton

Patent abstract

The present invention encompasses a method of treating a disease by maintaining chronic steady state serum levels of a GLP-1 compound within a specified range.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7989585 Chronic treatment regimen using glucagon-like insulinotropic peptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API